Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLTE Belite Bio, Inc.

交易中 05-02 15:16:27 EDT

62.41

+0.51

+0.82%

最高62.90	最低60.60	成交量1.90万
今开62.55	昨收61.90	日振幅3.72%
总市值19.87亿	流通市值8.92亿	总股本3,184万
成交额118.44万	换手率0.13%	流通股本1,429万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":62.41,"timestamp":1746213379530,"preClose":61.9,"halted":0,"volume":19013,"delay":0,"floatShares":14286650,"shares":31837660,"eps":-1.183559,"marketStatus":"交易中","change":0.51,"latestTime":"05-02 15:16:27 EDT","open":62.55,"high":62.9,"low":60.6,"amount":1184364.184368,"amplitude":0.037157,"askPrice":63.1,"askSize":300,"bidPrice":62.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.183559,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1651204800000,"exchange":"NASDAQ","adjPreClose":61.9,"preHourTrading":{"tag":"盘前","latestPrice":62.91,"preClose":61.9,"latestTime":"09:28 EDT","volume":742,"amount":47196.418486,"timestamp":1746192480040},"postHourTrading":{"tag":"盘后","latestPrice":61.9,"preClose":61.9,"latestTime":"16:05 EDT","volume":30,"amount":1857,"timestamp":1746129908473},"volumeRatio":0.852506},"requestUrl":"/m/hq/s/BLTE","defaultTab":"news","newsList":[{"id":"2529532932","title":"Belite Bio Inc盘中异动 股价大涨6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529532932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529532932?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:46","pubTimestamp":1745340361,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时46分，Belite Bio Inc股票出现波动，股价快速拉升6.09%。截至发稿，该股报58.02美元/股，成交量1.26万股，换手率0.04%，振幅4.49%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，Moolec Science Sa C/Wts 、Portage Biotech Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Ocean Biomedical, Inc.、Portage Biotech Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为209.57%、184.92%、145.34%，振幅较大的相关个股有Scorpius Holdings, Inc.、Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为102.79%、90.00%、75.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230046019740e815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230046019740e815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2518210273","title":"Belite Bio Inc盘中异动 早盘大幅上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518210273?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613476,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Belite Bio Inc股票出现波动，股价大幅上涨6.03%。截至发稿，该股报67.00美元/股，成交量1162股，换手率0.00%，振幅0.00%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.59%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213117964035a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213117964035a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2517602164","title":"Belite Bio Inc盘中异动 快速拉升5.30%报60.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517602164?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:53","pubTimestamp":1741110821,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时53分，Belite Bio Inc股票出现波动，股价大幅拉升5.30%。截至发稿，该股报60.20美元/股，成交量2.2093万股，换手率0.07%，振幅6.12%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.28%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305015342989bdd5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305015342989bdd5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2516652728","title":"Belite Bio Inc盘中异动 下午盘快速拉升5.23%报60.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652728?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:49","pubTimestamp":1741027758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时49分，Belite Bio Inc股票出现波动，股价急速拉升5.23%。截至发稿，该股报60.19美元/股，成交量3.8615万股，换手率0.12%，振幅4.15%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.61%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024918989a496c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024918989a496c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2516374952","title":"Belite Bio Inc盘中异动 临近午盘股价大跌5.11%报55.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516374952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516374952?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:46","pubTimestamp":1740761160,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时46分，Belite Bio Inc股票出现波动，股价大幅跳水5.11%。截至发稿，该股报55.29美元/股，成交量3.3522万股，换手率0.11%，振幅4.96%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.31%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301004601abe10a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301004601abe10a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2514638304","title":"Belite Bio Inc盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514638304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514638304?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666769,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Belite Bio Inc股票出现波动，股价大幅上涨5.32%。截至发稿，该股报58.45美元/股，成交量1.5494万股，换手率0.05%，振幅1.80%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.31%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223249abdf6ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223249abdf6ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2510323337","title":"Belite Bio Inc盘中异动 大幅上涨5.95%报57.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510323337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510323337?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:21","pubTimestamp":1739294494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时21分，Belite Bio Inc股票出现波动，股价快速上涨5.95%。截至发稿，该股报57.00美元/股，成交量9139股，换手率0.03%，振幅5.24%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为1.89%。其相关个股中，Omega Therapeutics, Inc.、Oramed Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3036.61%、1356.45%、446.63%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212012135961f64d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212012135961f64d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2510896990","title":"Belite Bio Inc盘中异动 股价大跌5.23%报54.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510896990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510896990?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:39","pubTimestamp":1739212789,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时39分，Belite Bio Inc股票出现波动，股价急速跳水5.23%。截至发稿，该股报54.52美元/股，成交量2.6437万股，换手率0.08%，振幅4.94%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.34%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211023949961e2ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211023949961e2ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2506846975","title":"Belite Bio Inc盘中异动 快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506846975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506846975?lang=zh_cn&edition=full","pubTime":"2025-01-28 03:54","pubTimestamp":1738007669,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时54分，Belite Bio Inc股票出现异动，股价大幅跳水5.08%。截至发稿，该股报56.40美元/股，成交量1.3259万股，换手率0.04%，振幅4.21%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.74%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035430abba9f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035430abba9f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2505520607","title":"Benchmark：维持Belite Bio(BLTE.US)评级，由买入调整至买入评级, 目标价由57.00美元调整至79.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505520607","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505520607?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:55","pubTimestamp":1737478539,"startTime":"0","endTime":"0","summary":"Benchmark：维持Belite Bio(BLTE.US)评级，由买入调整至买入评级, 目标价由57.00美元调整至79.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22005547678767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BLTE"],"gpt_icon":0},{"id":"2505272861","title":"Belite Bio Inc盘中异动 早盘股价大涨5.89%报59.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272861?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:46","pubTimestamp":1737470777,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时46分，Belite Bio Inc股票出现波动，股价快速拉升5.89%。截至发稿，该股报59.52美元/股，成交量7468股，换手率0.02%，振幅4.34%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.12%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224617960bbc5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224617960bbc5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2504160578","title":"Belite Bio Inc盘中异动 大幅上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504160578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504160578?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:22","pubTimestamp":1737127365,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时22分，Belite Bio Inc股票出现异动，股价大幅上涨5.43%。截至发稿，该股报55.92美元/股，成交量1.2718万股，换手率0.04%，振幅3.47%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.03%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232245a225c770&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232245a225c770&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2503918729","title":"Belite Bio Inc盘中异动 早盘急速下挫5.23%报52.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503918729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503918729?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:43","pubTimestamp":1737038601,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时43分，Belite Bio Inc股票出现异动，股价大幅下挫5.23%。截至发稿，该股报52.03美元/股，成交量8100股，换手率0.03%，振幅1.40%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.06%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622432198688e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622432198688e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2502688083","title":"Belite Bio Inc盘中异动 急速跳水5.28%报55.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502688083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502688083?lang=zh_cn&edition=full","pubTime":"2025-01-09 05:00","pubTimestamp":1736370059,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日05时00分，Belite Bio Inc股票出现波动，股价快速跳水5.28%。截至发稿，该股报55.66美元/股，成交量2.1394万股，换手率0.07%，振幅5.45%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.47%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109050059985fb375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109050059985fb375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2501258231","title":"Belite Bio Inc盘中异动 股价大跌6.44%报58.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501258231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501258231?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:48","pubTimestamp":1736174903,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时48分，Belite Bio Inc股票出现波动，股价大幅跳水6.44%。截至发稿，该股报58.09美元/股，成交量1.0674万股，换手率0.03%，振幅6.46%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.19%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106224824aba08cc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106224824aba08cc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2500461551","title":"Belite Bio Inc盘中异动 临近午盘股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500461551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500461551?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:33","pubTimestamp":1735922025,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时33分，Belite Bio Inc股票出现波动，股价大幅下挫5.78%。截至发稿，该股报61.02美元/股，成交量2.8534万股，换手率0.09%，振幅4.65%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.55%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104003346a2148234&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104003346a2148234&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2500972674","title":"Belite Bio Inc盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500972674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500972674?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:20","pubTimestamp":1735838409,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时20分，Belite Bio Inc股票出现异动，股价快速上涨5.39%。截至发稿，该股报66.50美元/股，成交量1.2291万股，换手率0.04%，振幅4.87%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.67%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301200995f6bad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301200995f6bad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2490771247","title":"Belite Bio Inc盘中异动 早盘大幅下挫5.07%报70.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490771247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490771247?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:38","pubTimestamp":1733758717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时38分，Belite Bio Inc股票出现波动，股价急速跳水5.07%。截至发稿，该股报70.60美元/股，成交量2.332万股，换手率0.08%，振幅4.98%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.11%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233837984ac81d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233837984ac81d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2489393112","title":"Belite Bio Inc盘中异动 早盘股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489393112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489393112?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:31","pubTimestamp":1733495506,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时31分，Belite Bio Inc股票出现波动，股价急速上涨6.08%。截至发稿，该股报68.97美元/股，成交量1.0744万股，换手率0.03%，振幅2.11%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.29%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223146a1d96ee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223146a1d96ee7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2489468329","title":"Belite Bio Inc盘中异动 大幅拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468329?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:34","pubTimestamp":1733409296,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时34分，Belite Bio Inc股票出现波动，股价急速上涨5.99%。截至发稿，该股报71.00美元/股，成交量2.8379万股，换手率0.09%，振幅1.72%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.09%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522345798e59e2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522345798e59e2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.belitebio.com","stockEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.0477},{"period":"3month","weight":0.0665},{"period":"6month","weight":-0.1144},{"period":"1year","weight":0.509},{"period":"ytd","weight":-0.019}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Belite Bio, Inc于2018年3月27日在开曼群岛注册成立。该公司是一家临床阶段的生物制药及药物开发公司，专注于针对目前无法治疗的眼部疾病的新疗法，这些疾病涉及有重大未满足医疗需求的视网膜变性，例如（i）萎缩性年龄相关性黄斑变性（AMD），通常称为地理萎缩（GA），或晚期干性AMD，和（ii）常染色体隐性遗传Stargardt病1型，或STGD1，这两种疾病都会导致进行性视力丧失，导致永久性失明。该公司的药物研发管道还包括一种小分子口服复方药物，用于治疗代谢性疾病，如非酒精性脂肪肝、非酒精性脂肪性肝炎、NASH、2型糖尿病、T2D和痛风。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.046453},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052618},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.036455},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.0153},{"month":5,"riseRate":0.75,"avgChangeRate":0.052554},{"month":6,"riseRate":0.333333,"avgChangeRate":0.286454},{"month":7,"riseRate":1,"avgChangeRate":0.262512},{"month":8,"riseRate":0.333333,"avgChangeRate":0.139472},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.021637},{"month":10,"riseRate":0.666667,"avgChangeRate":0.155013},{"month":11,"riseRate":0.666667,"avgChangeRate":0.066185},{"month":12,"riseRate":0.333333,"avgChangeRate":0.001613}],"exchange":"NASDAQ","name":"Belite Bio, Inc.","nameEN":"Belite Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Belite Bio, Inc.,BLTE,Belite Bio, Inc.股票,Belite Bio, Inc.股票老虎,Belite Bio, Inc.股票老虎国际,Belite Bio, Inc.行情,Belite Bio, Inc.股票行情,Belite Bio, Inc.股价,Belite Bio, Inc.股市,Belite Bio, Inc.股票价格,Belite Bio, Inc.股票交易,Belite Bio, Inc.股票购买,Belite Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况